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SUMMARY
Apart from donor and recipient risk factors, the effect of center-related
factors has significant impact on graft survival after liver transplantation
(LT). To investigate this effect in Eurotransplant, a retrospective database
analysis was performed, including all LT’s in adult recipients (≥18 years)
in the Eurotransplant region from 1.1.2007 until 31.12.2013. Additionally,
a survey was sent out to all transplant centers requesting information on
surgeons’ experience and exposure. In total, 10 265 LT’s were included
(median follow-up 3.3 years), performed in 39 transplant centers. Funnel
plots showed significant differences in graft survival between the transplant
centers. After correction for donor and recipient risk, with the Eurotrans-
plant donor risk index (ET-DRI) and the simplified recipient risk index
(sRRI) and random effects, these differences diminished. Mean historical
volume (in the preceding 5 years) was a significant (P < 0.001), nonlinear
marker for graft survival in the multivariate analysis. This study demon-
strates that funnel plots can be used for benchmarking purposes in LT.
Case-mix correction can be performed with the use of the ET-DRI and
sRRI. The center effect encompasses the entire complex process of preoper-
ative workup, operation to follow-up.
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Introduction
Apart from known donor risk and recipient risk factors
[1–6], several studies have found that liver transplanta-
tion (LT) center factors represent significant predictors
of graft failure, independent of region, donor service
area, or donor and recipient factors [7]. The hypothesis
of center volume being the main ‘center-related’ risk
factor for post-LT survival was confirmed by several
studies from Europe [8] and the USA [9,10]; however,
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these studies did not correct for donor and/or recipient
risk. Northup et al. [11] showed that transplant center
volume was not a significant predictor for post-trans-
plant survival after correcting for disease severity and
multiple donor and recipient factors in the model for
end-stage liver disease (MELD) era. In the Eurotrans-
plant region, 1632 deceased donor LT’s were performed
in 2015 by 39 individual centers, leading to a mean of
42 LTs per center [12]. Consequently, this broad range
of low- and high-volume centers is likely to lead to a
difference in experience. For pancreas transplantations
in the Eurotransplant region, it was recently demon-
strated that high volume is associated with a reduction
in graft failure rates [13].
Besides center volume, there may be other factors
influencing differences in outcome between transplant
centers or a so-called center effect. Regulatory bodies in
many disciplines require analysis of outcome data. In
the Netherlands, the Dutch Surgical Colorectal Audit
(DSCA) was initiated in 2009 to monitor, evaluate, and
improve colorectal cancer care, coordinated by the
Dutch Institute for Clinical Auditing (DICA) is an
example of such an institute [14]. The collected data are
used as a quality measure and performance indicator
that make it possible for hospitals to benchmark their
own results [15]. Consequences of these types of reg-
istries are improvements of quality and performance.
Within the Eurotransplant region, results are currently
not evaluated in this way.
The objective of this study was to investigate the
effect of transplant center characteristics on outcome
after LT in the Eurotransplant region in addition to the
impact of donor risk (ET-DRI) [5] and recipient risk
(sRRI) [6] in an attempt to provide data that can be
used to comparatively evaluate the outcome of liver
transplant centers, corrected for donor and recipient
case-mix (quality and performance benchmarking), in a
balanced, adjusted way.
Methods
Data selection
All deceased donor LT’s performed in adult recipients
(≥18 years) from January 1, 2007 till December 31,
2013 in the Eurotransplant region were included to
perform a retrospective database analysis. Eurotrans-
plant is a nonprofit organization that facilitates patient-
oriented allocation and cross-border exchange of
deceased donor organs and consists of eight countries
(member states): Austria, Belgium, Croatia, Germany,
Hungary, Luxembourg (has no LT center), the Nether-
lands, and Slovenia. Liver allocation in the Eurotrans-
plant region is discussed in detail by Jochmans et al.
[16]. All basic donor, recipient and center characteristics
(Tables 1 and 2) and follow-up data were obtained
from the Eurotransplant Network Information System
and the Eurotransplant Liver Registry. Follow-up data
from the Eurotransplant centers are uploaded individu-
ally to the Eurotransplant database, and Eurotransplant
delivers these follow-up data to the ELTR database. So,
every center in Eurotransplant indirectly delivers data to
the European Liver Transplant Registry (ELTR). A
detailed survey on individual experience of LT surgeons
was sent to each individual Eurotransplant transplant
center (Table S1). The Eurotransplant Liver Intestine
Table 1. Donor and transplant characteristics
(N = 10 265).
n (%)/median
(25th–75th percentile)
Donor factor
Age (years) 53 (42–65)
Height (cm) 173 (165–180)
Weight (kg) 75 (68–85)
BMI 25 (23–28)
Last GGT (U/l) 38 (20–86)
Sex
Male 5444 (53%)
Female 4821 (47%)
Cause of death
Trauma 2178 (21%)
CVA 6286 (61%)
Anoxia 1014 (9.9%)
Other/unknown 787 (7.7%)
DCD 454 (4.4%)
Split liver 308 (3.0%)
Transplant factor
Allocation
Local 2565 (25%)
Regional 2558 (25%)
Extraregional 5142 (50%)
Rescue allocation 2540 (25%)
Cold ischemia time (h) 8.82 (6.98–10.72)
ET-DRI 1.89 (1.53–2.22)
Number of transplants according to center volume
(according to Burroughs et al.)
Low (≤36 transplants) 2602 (25)
Median (36–69 transplants) 5084 (50)
High (≥70 transplants) 2579 (25)
BMI, body mass index; GGT, gamma glutamyl-transferase;
CVA, cerebral vascular accident; DCD, donation after circula-
tory determination of death; ET-DRI, Eurotransplant donor
risk index.
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Advisory Committee and Eurotransplant Board
approved the study protocol for this study. All data
were anonymized for country and transplant center.
The center-specific data were obtained by a specifi-
cally designed survey that was sent to all Eurotransplant
LT centers (Table S1). Here, we specifically focused on
the effect on center experience by transplant volume,
which can be defined in many ways. In this study, the
following four potential surrogate measures were ana-
lyzed: annual volume (the total number of transplants
performed in that same year), historical volume (the
mean of transplants performed in the five directly pre-
ceding years), surgical exposure (the sum of the number
of transplants divided by the sum of active years of all
transplant surgeons from that center both in the study
period), and surgical experience (the sum of the years
of experience in LT of all surgeons divided by the num-
ber of surgeons in the center). To categorize and
compare center volume, the volume limits from Bur-
roughs et al. [17] were used (Table 3): low (≤36 trans-
plants), median (36–69 transplants), and high (≥70
transplants).
Statistical analysis
Primary outcome used in the analyses was graft survival,
defined as the period between the date of transplanta-
tion and date of retransplantation or date of recipient
death, which ever occurred first (death-uncensored graft
survival). Follow-up data until May 2016 were used in
the analyses. In case of missing follow-up data, trans-
plants were not included in the multivariate analyses.
For all donors, the Eurotransplant donor risk index
(ET-DRI) [5] (factors: donor age, cause of death, latest
gamma glutamyl-transferase, donation after circulatory
determination of death (DCD), split LT, allocation, cold
ischemia time, and rescue allocation; definition
described in Eurotransplant Manual [18] and by Joch-
mans et al. [16]) was calculated and for all recipients
the simplified recipient risk index (sRRI) (factors: recip-
ient age, sex, etiology of disease, laboratory MELD
score, and repeated transplant). In case of missing val-
ues for donor, gamma glutamyl-transferase median val-
ues were used (28 U/l, 1.7% missing) and in case of
missing cold ischemia times (43.8% missing), values
were imputed five times based on a normal distribution
according to the factor allocation (cold ischemia times
used were as follows: local 7.41 h, regional 8.55 h,
extraregional 9.80 h) in a fivefold database, in order to
calculate the ET-DRI. Rubin’s rules were used to pool
estimates obtained from different imputed datasets. If
patients received renal replacement therapy, the crea-
tinine value was set at 4 (as of 16.12.2006, implementa-
tion of MELD for liver allocation). The MELD score
was rounded to the nearest whole value (range 6–40).
Two centers were excluded from the analysis due to less
than 10 transplantations in the total study period, and
one center was excluded based on potential data manip-
ulation in the past [19,20].
Clinical characteristics were summarized by median
and 25th–75th percentile or number and percentage for
categorical factors. Comparison between groups was
made using chi-square (categorical factors) or a
Kruskall–Wallis test (numerical factors). Survival analy-
ses were performed using Kaplan–Meier survival mod-
els, and multivariate analyses were performed using Cox
regression models. Uncorrected/corrected funnel plots
were obtained by fitting Cox proportional hazards mod-
els with fixed effects for center, unadjusted/adjusted by
Table 2. Recipient characteristics (N = 10 265).
n (%)/median
(25th–75th percentile)
Recipient factors
Age (years) 55 (48–61)
Height (cm) 173 (167–180)
Weight (kg) 78 (67–89)
BMI 25.7 (22.9–29.0)
Lab-MELD 18 (12–30)
Sex
Male 6881 (67%)
Female 3384 (33%)
Primary disease on WL
Metabolic 302 (3%)
Acute 966 (9%)
Cholestatic 1229 (12%)
Alcoholic 2335 (23%)
Malignant 2164 (21%)
HBV 327 (3%)
HCV 1042 (10%)
Other cirrhosis 1267 (12%)
Other/unknown 633 (6.2%)
Repeat transplant 1299 (13%)
Lab-MELD category
<15 3830 (37%)
15–25 2947 (29%)
26–34 1751 (17%)
≥35 1686 (16%)
Missing values 51 (1%)
sRRI 1.96 (1.59–2.63)
BMI, body mass index; lab-MELD, laboratory model for end-
stage liver disease score; WL, waiting list; HBV, hepatitis B
virus; HCV, hepatitis C virus; sRRI, simplified recipient risk
index.
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ET-DRI and sRRI (both log-transformed). Unadjusted
and adjusted center effects (log hazard ratios) were then
centered and plotted against the precision (1 over vari-
ance) of the centered estimates, calculated under the
null hypothesis of no difference between centers. Confi-
dence limits are plotted as exp(1.96/sqrt(precision))
for 95% confidence limits and exp(2.58/sqrt(preci-
sion)) for 99% confidence limits. The funnel plot was
used to demonstrate transplant centers with graft sur-
vival rates that were significantly higher or lower than
the mean within Eurotransplant (high and low outliers,
transplant centers that are outside the 95% or 99% con-
fidence limits). Two ways of correcting for possible cor-
relation of outcomes were considered. The first was by
adjusting standard errors using sandwich estimators; the
second was using random-effects models. Analysis of
volume–outcome relations was performed by consider-
ing the mean volume in the center over the 5 years pre-
ceding each transplantation. This “historical” volume
was used to guard against reverse causation, the possi-
bility that bad/good performance of a center leads to
lower/higher volume afterward [21]. In Fig. 3, that
shows the analysis of the relationship between volume
and transplantation, P-splines with four degrees of free-
dom were used to test for and model nonlinear rela-
tions between volume and outcome. The mean
historical volume may vary every following year. For all
analyses, a P-value of <0.05 was considered significant.
All analyses were performed with SPSS (version 22.0) and
R (version 3.3.2).
Results
The total number of included transplants was 10 265 per-
formed in thirty-nine transplant centers (range of 21–768
LTs per center in the whole study period) during the 7-
year study period (median follow-up time 3.3 years, max-
imum follow-up time 9.2 years). Follow-up data were
missing in 387 cases (96% completeness). Demographics
of donor and transplant characteristics are shown in
Table 1. Median donor age was 53 years, 4.4% of all
transplants were with DCD allografts, 25% with a rescue
allograft, and median ET-DRI was 1.89. Twenty-five per-
cent of all transplants were performed in a low-volume
center, 50% in an intermediate volume, and 25% in a
large volume center according to the “Burroughs volume
Table 3. Center characteristics according to low/median/high categories (N = 10 265 transplants, n = 39 transplant
centers).
Factors
Center volume
P-value
Low (n = 20 centers)
n = 2602 transplants
Medium (n = 15 centers)
n = 5084 transplants
High (n = 4 centers)
n = 2579 transplants
Donor age (year), median (25th–75th %) 52 (41–63) 52 (41–63) 56 (45–69) <0.001
Donor BMI, median (25th–75th %) 25 (23–28) 25 (23–28) 26 (24–28) <0.001
Donor, male sex, n (%) 1405 (54) 2694 (53) 1345 (52) 0.411
Donor DCD, n (%) 196 (7.5) 258 (5.1) n/a <0.001
Split liver, n (%) 58 (2.2) 185 (3.6) 65 (2.5) 0.001
Allocation, n (%)
Local 573 (22) 1217 (24) 775 (30) <0.001
Regional 796 (31) 1384 (27) 378 (15)
Extraregional 1233 (47) 2483 (49) 1426 (55)
Rescue allocation, n (%) 618 (24) 1008 (20) 914 (35) <0.001
ET-DRI, median (25th–75th %) 1.88 (1.53–2.20) 1.86 (1.51–2.18) 1.92 (1.63–2.31)
Recipient age (year), median (25th–75th %) 55 (48–62) 55 (47–61) 54 (48–60) <0.001
Recipient BMI, median (25th–75th %) 26 (23–29) 26 (23–29) 26 (23–29) 0.258
Recipient lab-MELD, median (25th–75th %) 18 (11-31) 18 (11–30) 17 (12–28) 0.687
Recipient, male sex, n (%) 1791 (69) 3399 (67) 1691 (66) 0.041
Recipient primary disease, n (%)
Acute 247 (10) 560 (11) 152 (5.9) 0.179
Cholestatic 240 (9) 660 (13) 329 (13)
HCV 218 (8) 464 (9) 360 (14)
sRRI 1.91 (1.59–2.63) 1.98 (1.63–2.64) 1.91 (1.59–2.60)
BMI, body mass index; DCD, donation after circulatory determination of death; ET-DRI, Eurotransplant donor risk index; lab-
MELD, laboratory model for end-stage liver disease score; HCV, hepatitis C virus; sRRI, simplified recipient risk index.
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categories,” which were used as a practical example for
center volume in this study [17]. A total of 30 centers (of
the included 39 centers) returned a filled-out survey
(75% response rate), equally divided amongst the small
(80% response), medium (80%% response), and large
center size categories (75% response). Demographics of
recipient characteristics are shown in Table 2. Median
recipient age was 55 years, with a median lab-MELD at
transplant of 18. The most frequently transplanted pri-
mary liver disease was alcoholic cirrhosis (23%) followed
by patients with a malignant etiology of liver disease
(21%). The number of repeated LT was 13%.
Center effect analyses
Demographics categorized according to low, intermedi-
ate, or large center size are shown in Table 3. Median
donor age was the highest in the high-volume centers
(56 vs. 52 years P =< 0.001), and a higher percentage of
extraregional (55% vs. 47% and 49%, P < 0.001) and
rescue allocated liver allografts (35% vs. 24% and 20%,
P < 0.001) were transplanted in high-volume centers.
No DCD donors were transplanted in the high-volume
centers, the percentage of DCD transplantation was the
highest in low-volume centers (7.5% vs. 5.1%,
P < 0.001). Split liver transplantation was the highest in
intermediate-volume category (P = 0.001).
The first step was to analyze graft survival per trans-
plant center, shown in Fig. 1a (uncorrected graft sur-
vival), in a funnel plot. Next, a funnel plot corrected for
donor–recipient case-mix (donor risk measured by ET-
DRI and recipient risk by sRRI) was constructed
(Fig. 1b). In this figure with “risk-adjusted” graft sur-
vival rates, there were eight centers with an outcome
below average (orange and red dots, hazard ratio [HR]
above the 95% confidence interval), ten centers with an
outcome above average (blue and green dots, HR below
the 95% confidence interval), and the remaining
twenty-one centers were within the 95% confidence lim-
its (the average/majority cohort, purple dots). Differ-
ences in donor, transplant, and recipient characteristics
for the centers are shown in Table 4 according to their
outcome/performance. Median donor age was highest
in the below-average centers (55 years vs. 52 years and
53 years, P < 0.001) as well as the donor BMI (26 vs.
25, P < 0.001). There were no DCD transplants
performed in the below-average centers, whereas
the highest percentage of DCD donors was used in the
above-average centers (11% vs. 2%, P < 0.001). The
below-average centers transplanted the most extrare-
gional (62% vs. 36% and 54%, P < 0.001) and rescue
allocated (39% vs. 22% and 19%, P < 0.001) allografts.
The above-average centers transplanted patients with
the lowest median MELD score (16 vs. 18, P < 0.001).
Figure 2 shows a ranking of all thirty-nine transplant
centers, ranked by the HR for decreased graft survival.
Figure 2a,b shows the unadjusted and (case-mix)
adjusted HRs, respectively. Figure 2c shows the HR for
decreased graft survival, adjusted for case-mix and ran-
dom effect. This analysis shows that after using a ran-
dom-effects model, there were still six centers with a
significant below-average outcome than the mean and
ten centers with a significant outcome above average.
Measures for center-related effects
The next step was to analyze which of the center-related
factors (annual volume, historical volume, surgical
experience, and surgical expertise) was associated with
graft survival. The following results were found: annual
volume P < 0.001, historical volume P = 0.015
Figure 1 (a) Funnel plot with uncorrected graft survival rates plotted
for every liver transplant center in Eurotransplant; (b) funnel plot with
graft survival rates corrected for risk by donor risk Eurotransplant
donor risk index (ET-DRI) and recipient risk simplified recipient risk
index (sRRI), plotted for every liver transplant center in Eurotrans-
plant: (i) orange and red dots: centers performing below average
(hazard ratio above the 95% confidence interval), (ii) purple dots:
centers performing within the average range, and (iii) green and blue
dots: centers performing above average (hazard ratio below the
95% confidence interval).
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(nonlinearity test P < 0.001), surgical experience
P < 0.001 (nonlinearity test P < 0.001), and surgical
exposure P = 0.029 (nonlinearity test P < 0.001). For
further analysis, we chose to use the historical volume
as a marker for center experience, as it has a significant
relation with graft survival, and historical volume is a
reliable way of analyzing this factor in a longitudinal
way according to the literature [21]. Figure 3 shows the
results of the multivariate analysis of historical volume
and the relation with the risk (HR) for decreased graft
survival. The relation is nonlinear. The precise form of
the curve has to be interpreted with caution, but a
decreasing relative risk can be seen until the center vol-
ume reaches approximately 50 transplants (historical
volume). The relative risk subsequently increases until
around 100 transplants and finally decreases again.
Discussion
This study, performed with data from the Eurotrans-
plant database covering 7 years from 2007 till 2013,
confirms that outcome (death-uncensored graft sur-
vival) differs between transplant centers in the Euro-
transplant region, demonstrated with the use of funnel
plots. When correcting these funnel plots of center-
related risks for donor and recipient risks, with the
ET-DRI and sRRI respectively, four (poor performing)
centers came within the confidence intervals for graft
survival. When the centers were ranked according to
HR, the risk was more clearly delineated. This shows
the possibility to demonstrate graft survival, corrected
for donor–recipient case-mix. In light of quality control
and transparency, openly sharing of outcome data is
very important and requires centers to be willing to
share their data. It is clear that the “best” organs in the
“best” recipients risk have the best results. Hesitation or
reluctance to transplant high-risk organs into high-risk
recipients or to share outcome data when results seem
suboptimal as compared to other centers should be
overcome. Correction for case-mix is essential and will
promote sharing of outcome data amongst transplant
centers. In the future, it would be interesting if centers
Table 4. Center characteristics according to outcome in a corrected funnel plot outcome. Average outcome is defined
as within the 95% confidence interval, poor above, and good below the 95% confidence interval (N = 10 265
transplants, n = 39 transplant centers).
Factors
Outcome
P-value
Poor performance
(n = 8 centers,
2091 transplants)
Average performance
(n = 21 centers,
5000 transplants)
Good performance
(n = 10 centers,
3174 transplants)
Donor age (year), median (25th–75th %) 55 (45–67) 52 (41–64) 53 (42–63) <0.001
Donor BMI, median (25th–75th %) 26 (24–28) 25 (23–28) 25 (23–28) <0.001
Donor, male sex, n (%) 1048 (50) 2679 (54%) 1717 (54%) 0.010
Donor DCD, n (%) n/a 95 (2%) 359 (11%) <0.001
Split liver, n (%) 36 (2%) 197 (4%) 75 (2%) <0.001
Allocation, n (%)
Local 348 (17%) 1210 (24%) 1007 (32%) <0.001
Regional 458 (22%) 1085 (22%) 1015 (32%)
Extra-regional 1258 (62%) 2705 (54%) 1152 (36%)
Rescue allocation, n (% 805 (39%) 1119 (22%) 616 (19%) <0.001
ET-DRI, median (25th–75th %) 1.98 (1.69–2.32) 1.86 (1.51–2.20) 1.83 (1.51–2.14) <0.001
Recipient age (year), median (25th–75th %) 55 (48–60) 55 (47–61) 56 (48–62) <0.001
Recipient BMI, median (25th–75th %) 26 (23–29) 26 (23–29) 26 (23–29) <0.001
Recipient, male sex, n (%) 1349 (65%) 3389 (68%) 2143 (68%) 0.022
Recipient lab-MELD, median (25th–75th %) 18 (11–32) 18 (12–31) 16 (10–27) <0.001
Recipient primary disease, n (%)
Acute 200 (10%) 509 (10%) 257 (8%) <0.001
Cholestatic 212 (10%) 647 (13%) 370 (12%)
HCV 220 (11%) 575 (12%) 247 (8%)
sRRI 1.97 (1.59–2.63) 1.97 (1.59–2.64) 1.87 (1.59–2.51) <0.001
BMI, body mass index; DCD, donation after circulatory determination of death; ET-DRI, Eurotransplant donor risk index; lab-
MELD, laboratory model for end-stage liver disease score; HCV, hepatitis C virus; sRRI, simplified recipient risk index.
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could access their own individual center performance
within the international allocation organization with
correction for case-mix, similarly as shown in this
study. This would likely improve awareness of perfor-
mance based on comparisons with other centers and
longitudinal developments and may thus contribute to
improving quality of care and transparency for the
whole transplant community.
The persisting differences between the transplant cen-
ters can be explained best by a “center effect.” This cen-
ter effect can be defined as all the factors that influence
outcome after LT, beyond typical factors such as donor
quality and recipient risk. In view of the large variation
of the practice of LT in the Eurotransplant region, these
factors are influenced by local protocols, waitlist man-
agement, acceptance policy (driven by access to liver
grafts or availability of liver donors, which varies
amongst Eurotransplant countries [12]), legal frame-
work (i.e., regarding the possibility of DCD LT), and
potentially other unknown factors. For example, DCD
LT is only performed in Belgium and the Netherlands.
The differences in risk-taking behaviors between the
low-/intermediate-/high-risk centers and the underper-
forming/medium/over performing centers, as demon-
strated in, respectively, Tables 3 and 4, could have been
partly caused by this variation between the Eurotrans-
plant countries. Not only surgical experience (skills and
quality), but also experience in the entire donor and
transplant process, from donor management to the fol-
low-up of recipients, may play a significant role. This
experience could partly be determined by the expertise
of the center or other contributors like logistical factors
or factors that are not readily appreciable in the analysis
of large databases (e.g., data that are not routinely col-
lected). Therefore, it is important when evaluating cen-
ter outcomes, to keep in mind that differences in case-
mix and waitlist mortality between centers exist.
In an attempt to make this more visible, we divided
the centers into three volume categories (low–interme-
diate–high). As an example, we used the proposed cate-
gories of the European Liver Transplant Registry
(ELTR) study by Burroughs et al. in 2006 [17]. Half of
all transplants were performed in intermediate-volume
centers. High-volume centers transplanted liver
Figure 2 (a) Ranking of all liver transplant centers in Eurotransplant
according to hazard ratio (ranked from low to average to high risk,
uncorrected for donor and recipient risk), with 95% confidence inter-
val. (b) Ranking of all liver transplant centers in Eurotransplant
according to hazard ratio (ranked from low to average to high risk,
corrected for donor risk Eurotransplant donor risk index (ET-DRI) and
recipient risk simplified recipient risk index (sRRI), with 95% confi-
dence interval. (c) Ranking of all liver transplant centers in Eurotrans-
plant according to hazard ratio (ranked from low to average to high
risk, corrected for donor risk ET-DRI, recipient risk sRRI, and random
effect, with 95% confidence interval.
Figure 3 Effect of center historical volume (the average number of
transplants performed in the five directly preceding years) on the risk
(hazard ratio) for decreased graft survival after liver transplantation
(nonlinear relation).
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allografts with the highest median donor age, with high-
est percentage of extraregional allocated or rescue allo-
cated allografts, as well as the highest percentage of
patients listed with hepatitis C. These higher donor and
recipient risks would potentially lead to inferior out-
comes and were therefore corrected using the ET-DRI
(donor risk), sRRI (recipient risk), and by performing a
random-effects analysis. Even after these random-effects
analyses centers with a significantly lower/higher risk
than average remained.
To determine the best surrogate marker for center
experience, we investigated four factors potentially asso-
ciated with center outcome: annual volume, historical
volume (mean volume over the past 5 years), surgical
experience, and surgical exposure. The latter two factors
were determined by a survey independent of the data
analysis that was sent out to all Eurotransplant LT cen-
ters. The reason for choosing historical volume as the
putatively best surrogate marker for center experience
was the significant association with outcome in the
analyses and based on published literature [21]. How-
ever, there are many differences in surgical practice
between the Eurotransplant centers, for example,
whether a LT is being performed by one or two trans-
plant surgeons or the organization of standard operat-
ing procedures in transplantation medicine. A separate
analysis, in which the specific size of the center and its
association with decreased graft survival were evaluated,
showed that there was no linear relation with outcome.
The results showed a curve with two optimal points
(low HR) with regard to graft survival; around 50 trans-
plants per year and when performing more than 120
transplants per year (historical volume). These results
differ from findings by Burroughs et al. [17] in another
European study with ELTR data, published in 2006.
Even though that study was performed with data of
transplants performed between 1988 and 2003, it was a
large dataset with 34 664 LTs, which showed that cen-
ters with ≥70 transplants per year were associated with
improved patient survival at 3-month and 1-year fol-
low-up. Based on these considerations, a limit for
improved or decreased graft survival such as that a
transplant center that performs 69 transplants annually
would be a worse performer than a center with 70
transplants does not appear justified. In contrast, the
use of a range of the number of transplants, in which a
center would have less risk for decreased graft survival,
would be preferable. Another difference with the ELTR
study was the outcome end points employed. We
looked at medium-term (3 years) graft survival as
opposed to short-term patient survival, an approach
that may explain the difference in the range for the
decreased risk of center volume. The improved out-
comes for high-volume centers in Germany, one of the
Eurotransplant countries, were recently addressed in a
study by Nijboer et al. [22], and an editorial related to
this study also suggested that there was no linear rela-
tion between outcome and center size [23], which was
also seen in the present study. One explanation for this
effect could be that when a center grows beyond the 50
transplants, there will first be a transition period from
being an intermediate-volume to a high-volume center.
Eventually, the increased exposure will lead to better
results with an optimum that surpasses 120 transplants.
In 2013, Asrani et al. showed that the transplant cen-
ter represents a significant determinant of graft failure
that could provide an explanation for the disparities in
outcomes after LT, with data from the Organ Procure-
ment and Transplantation Network. Interestingly, there
was no effect of center volume when donor, recipient,
and transplant characteristics were taken into account.
The authors suggested that the differences in outcome
might well be explained by differences in surgical, medi-
cal, and/or nursing expertise that may influence the
quality of care at a transplant center [7]. Unfortunately,
these factors are generally not recorded in databases
such as the Scientific Registry of Transplant Recipients
and the Eurotransplant database. One way of looking
more closely to post-transplant results on a more
detailed (center) level would be with a cumulative sum
(CUSUM) analysis [24,25], performed by the centers
themselves. This might be a means to more rapidly
implement quality improvement and performance than
by means of retrospective database analyses. In light of
comparing results with other centers, the risk of the
center in relation to ET-DRI or sRRI might also be dif-
ferent.
There are several potential limitations of this study,
which represents a retrospective database analysis. Euro-
transplant collects many donor factors, but only basic
recipient data. To correct for recipient risk, we used the
sRRI that includes these basic factors as described previ-
ously. Nevertheless, additional relevant factors likely
exist that may play a role in determining outcome. But
because these were not recorded in the database, these
could therefore not be entered into the analysis. Unfor-
tunately, the cold ischemia times were incomplete for
44% of the transplants, which we countered by multiple
imputation based on the factor allocation. Altogether,
this will have only a limited impact on the ET-DRI cal-
culation, as there is a narrow range of cold ischemia
times. Another potential confounder could be the fact
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that the criteria for listing on the liver transplant wait-
list differ considerably per country (and even per trans-
plant center). This is also true for the decision process
of whom to transplant or not to transplant, which is
dependent on the availability of donors and the alloca-
tion system employed (MELD versus non-MELD coun-
tries), as well as specific legal frameworks. All these
considerations might have an impact on the center
effect. Currently, the best way to correct for (part of)
these factors is to use the ET-DRI and sRRI. Overall,
the graph in Fig. 3 demonstrates that additional factors
apart from the numerical performance of transplant
centers play into the probability of graft and patient
survival and that these associations have to be viewed
and interpreted with caution.
Conclusions
In conclusion, our study demonstrates a center effect in
liver transplantation in the Eurotransplant region by
specifically looking at outcome and volume on a center-
specific level. There are significant differences in graft
survival rates between the Eurotransplant liver trans-
plant centers. However, by correcting for donor and
recipient risks (ET-DRI and sRRI) and random effects,
these differences are partially corrected, and as such,
funnel plots can be used for benchmarking purposes.
The center effect consists of the whole process from
preoperative workup, operation to postoperative follow-
up. In this study, we also specifically analyzed center
(historical) volume. Although the results have to be
viewed with caution in light of the considerable differ-
ences across the countries within the Eurotransplant
region, a center effect appears to be a relevant factor
influencing outcome. In general, but certainly also for
the centers itself, it is important to get insight in this
center effect. Correcting for case-mix, using the donor–
recipient model (ET-DRI + sRRI), is an elegant tool for
such benchmarking efforts.
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